Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Island Press
Online
2020-04-28
DOI
10.1038/s41379-020-0553-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell composition
- (2020) Elizabeth Mitchell et al. MOLECULAR CARCINOGENESIS
- Estimating Residence Times of Lymphocytes in Ovine Lymph Nodes
- (2019) Margaret M. McDaniel et al. Frontiers in Immunology
- Ductal carcinoma in situ of the breast: immune cell composition according to subtype
- (2019) Marie Colombe Agahozo et al. MODERN PATHOLOGY
- Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study
- (2019) Hélène Dano et al. MODERN PATHOLOGY
- Mutation-Derived Neoantigens for Cancer Immunotherapy
- (2019) John C. Castle et al. Frontiers in Immunology
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
- (2018) Michael S. Toss et al. MODERN PATHOLOGY
- Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
- (2018) Marie Colombe Agahozo et al. MODERN PATHOLOGY
- Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ
- (2017) Islam Miligy et al. HISTOPATHOLOGY
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
- (2017) Maria Vittoria Dieci et al. SEMINARS IN CANCER BIOLOGY
- The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
- (2016) G. Pruneri et al. ANNALS OF ONCOLOGY
- Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
- (2016) Michael J. Campbell et al. BREAST CANCER RESEARCH AND TREATMENT
- Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
- (2016) Shusma C. Doebar et al. BREAST CANCER RESEARCH AND TREATMENT
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- The immune microenvironment of breast ductal carcinoma in situ
- (2016) Elizabeth Thompson et al. MODERN PATHOLOGY
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- CD8+tumor-infiltrating lymphocytes contribute to spontaneous “healing” in HER2-positive ductal carcinoma in situ
- (2016) Michi Morita et al. Cancer Medicine
- Regressive Change in High-Grade Ductal Carcinoma In Situ of the Breast
- (2015) Jason K. Wasserman et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
- (2012) N R West et al. BRITISH JOURNAL OF CANCER
- The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer
- (2012) Zahra M.A. Mohammed et al. CANCER TREATMENT REVIEWS
- Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
- (2012) Archie Bleyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
- (2011) Fangfang Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
- (2010) Sahar M. A. Mahmoud et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterization of High-grade Ductal Carcinoma In Situ With and Without Regressive Changes
- (2009) Mamatha Chivukula et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started